長期投資家のためのIR情報
 バリュートレンド
  1. HOME
  2. バリュートレンド
  3. 【4581】大正製薬ホールディングス

【4581】大正製薬ホールディングス 〔上場廃止〕
ー(上場廃止)大衆薬『リポビタンD』。
類似企業：
【業界1位】 小野薬品工業
【売上同水準】 ロート製薬 参天製薬


東証スタンダード
医薬
＞
医他
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)		 対前回 修正率 修正率 営業利益
(百万円)		 対前回 修正率 修正率 経常利益
(百万円)		 対前回 修正率 修正率 当期利益
(百万円)		 対前回 修正率 修正率
2024.03 2023/11/10 Q2予 319,000 ↑ +1.4% +1.4% 20,500 ↑ +10.8% +10.8% 25,000 ↑ +13.6% +13.6% 10,500 ↓ -19.2% -19.2%
2024.03 2023/08/04 Q1予 314,500 → 0.0% 0.0% 18,500 → 0.0% 0.0% 22,000 → 0.0% 0.0% 13,000 → 0.0% 0.0%
2024.03 2023/05/11 当初予 314,500 - - - 18,500 - - - 22,000 - - - 13,000 - - -
2023.03 2023/05/11 実 301,381 ↓ -0.5% +7.4% 23,018 ↓ -2.1% +43.9% 30,444 ↑ +3.2% +52.2% 18,997 ↓ -0.0% +58.3%
2023.03 2023/02/09 Q3予 303,000 ↑ +8.0% +8.0% 23,500 ↑ +46.9% +46.9% 29,500 ↑ +47.5% +47.5% 19,000 ↑ +58.3% +58.3%
2023.03 2022/11/10 Q2予 280,500 → 0.0% 0.0% 16,000 → 0.0% 0.0% 20,000 → 0.0% 0.0% 12,000 → 0.0% 0.0%
2023.03 2022/08/03 Q1予 280,500 → 0.0% 0.0% 16,000 → 0.0% 0.0% 20,000 → 0.0% 0.0% 12,000 → 0.0% 0.0%
2023.03 2022/05/13 当初予 280,500 - - - 16,000 - - - 20,000 - - - 12,000 - - -
2022.03 2022/05/13 実 268,203 ↓ -0.3% -0.3% 10,743 ↓ -2.3% -25.9% 18,412 ↑ +18.8% -0.5% 13,122 ↑ +14.1% +25.0%
2022.03 2022/02/01 Q3予 269,000 → 0.0% 0.0% 11,000 ↓ -24.1% -24.1% 15,500 ↓ -16.2% -16.2% 11,500 ↑ +9.5% +9.5%
2022.03 2021/11/09 Q2予 269,000 → 0.0% 0.0% 14,500 → 0.0% 0.0% 18,500 → 0.0% 0.0% 10,500 → 0.0% 0.0%
2022.03 2021/08/05 Q1予 269,000 → 0.0% 0.0% 14,500 → 0.0% 0.0% 18,500 → 0.0% 0.0% 10,500 → 0.0% 0.0%
2022.03 2021/05/14 当初予 269,000 - - - 14,500 - - - 18,500 - - - 10,500 - - -
2021.03 2021/05/14 実 281,980 ↓ -0.4% -2.6% 19,965 ↓ -4.9% -0.2% 25,946 ↑ +1.7% +12.8% 13,316 ↓ -4.9% +2.4%
2021.03 2021/02/04 Q3予 283,000 ↓ -2.2% -2.2% 21,000 ↑ +5.0% +5.0% 25,500 ↑ +10.9% +10.9% 14,000 ↑ +7.7% +7.7%
2021.03 2020/10/29 Q2予 289,500 → 0.0% 0.0% 20,000 → 0.0% 0.0% 23,000 → 0.0% 0.0% 13,000 → 0.0% 0.0%
2021.03 2020/08/05 Q1予 289,500 → 0.0% 0.0% 20,000 → 0.0% 0.0% 23,000 → 0.0% 0.0% 13,000 → 0.0% 0.0%
2021.03 2020/05/14 当初予 289,500 - - - 20,000 - - - 23,000 - - - 13,000 - - -
2020.03 2020/05/14 実 288,527 ↓ -0.7% +13.8% 21,460 ↓ -0.2% -39.5% 25,010 ↓ -3.8% -41.2% 20,531 ↓ -2.2% -28.0%
2020.03 2020/02/14 修正予 290,500 ↓ -1.0% +14.6% 21,500 ↓ -34.8% -39.4% 26,000 ↓ -29.7% -38.8% 21,000 ↓ -28.8% -26.3%
2020.03 2019/10/30 Q2予 293,500 → 0.0% +15.8% 33,000 → 0.0% -7.0% 37,000 → 0.0% -12.9% 29,500 → 0.0% +3.5%
2020.03 2019/07/29 Q1予 293,500 ↑ +15.8% +15.8% 33,000 ↓ -7.0% -7.0% 37,000 ↓ -12.9% -12.9% 29,500 ↑ +3.5% +3.5%
2020.03 2019/05/13 当初予 253,500 - - - 35,500 - - - 42,500 - - - 28,500 - - -
2019.03 2019/05/13 実 261,551 ↑ +0.0% -2.8% 31,211 ↓ -5.4% -5.4% 40,851 ↓ -3.9% +3.4% 48,593 ↓ -7.4% -12.4%
2019.03 2019/01/30 Q3予 261,500 ↓ -2.8% -2.8% 33,000 → 0.0% 0.0% 42,500 ↑ +7.6% +7.6% 52,500 ↓ -5.4% -5.4%
2019.03 2018/10/29 Q2予 269,000 → 0.0% 0.0% 33,000 → 0.0% 0.0% 39,500 → 0.0% 0.0% 55,500 → 0.0% 0.0%
2019.03 2018/08/01 Q1予 269,000 → 0.0% 0.0% 33,000 → 0.0% 0.0% 39,500 → 0.0% 0.0% 55,500 → 0.0% 0.0%
2019.03 2018/05/14 当初予 269,000 - - - 33,000 - - - 39,500 - - - 55,500 - - -
2018.03 2018/05/14 実 280,092 ↑ +0.2% +0.4% 36,977 ↑ +10.4% +29.7% 42,140 ↑ +9.5% +22.1% 31,679 ↑ +5.6% +32.0%
2018.03 2018/02/01 Q3予 279,500 ↑ +0.2% +0.2% 33,500 ↑ +17.5% +17.5% 38,500 ↑ +11.6% +11.6% 30,000 ↑ +25.0% +25.0%
2018.03 2017/10/30 Q2予 279,000 → 0.0% 0.0% 28,500 → 0.0% 0.0% 34,500 → 0.0% 0.0% 24,000 → 0.0% 0.0%
2018.03 2017/08/02 Q1予 279,000 → 0.0% 0.0% 28,500 → 0.0% 0.0% 34,500 → 0.0% 0.0% 24,000 → 0.0% 0.0%
2018.03 2017/05/15 当初予 279,000 - - - 28,500 - - - 34,500 - - - 24,000 - - -
2017.03 2017/05/15 実 279,773 ↓ -0.6% -1.8% 31,966 ↑ +4.8% +8.4% 38,036 ↑ +4.2% +4.2% 28,781 ↑ +4.7% +19.9%
2017.03 2017/02/02 Q3予 281,500 ↓ -1.2% -1.2% 30,500 ↑ +3.4% +3.4% 36,500 → 0.0% 0.0% 27,500 ↑ +14.6% +14.6%
2017.03 2016/10/31 Q2予 285,000 → 0.0% 0.0% 29,500 → 0.0% 0.0% 36,500 → 0.0% 0.0% 24,000 → 0.0% 0.0%
2017.03 2016/08/01 Q1予 285,000 → 0.0% 0.0% 29,500 → 0.0% 0.0% 36,500 → 0.0% 0.0% 24,000 → 0.0% 0.0%
2017.03 2016/05/16 当初予 285,000 - - - 29,500 - - - 36,500 - - - 24,000 - - -
2016.03 2016/05/16 実 290,135 ↑ +0.0% -1.6% 28,878 ↑ +7.0% +7.0% 36,775 ↑ +5.1% +5.1% 22,473 ↑ +4.5% +2.2%
2016.03 2016/02/03 Q3予 290,000 ↓ -1.7% -1.7% 27,000 → 0.0% 0.0% 35,000 → 0.0% 0.0% 21,500 ↓ -2.3% -2.3%
2016.03 2015/10/30 Q2予 295,000 → 0.0% 0.0% 27,000 → 0.0% 0.0% 35,000 → 0.0% 0.0% 22,000 → 0.0% 0.0%
2016.03 2015/07/30 Q1予 295,000 → 0.0% 0.0% 27,000 → 0.0% 0.0% 35,000 → 0.0% 0.0% 22,000 → 0.0% 0.0%
2016.03 2015/05/13 当初予 295,000 - - - 27,000 - - - 35,000 - - - 22,000 - - -
2015.03 2015/05/13 実 290,498 ↓ 0.0% -2.8% 31,974 ↑ +10.3% +4.8% 39,576 ↑ +7.0% +2.8% 24,528 ↑ +2.2% -3.8%
2015.03 2015/01/30 Q3予 290,500 ↓ -0.9% -2.8% 29,000 → 0.0% -4.9% 37,000 → 0.0% -3.9% 24,000 → 0.0% -5.9%
2015.03 2014/10/31 Q2予 293,000 ↓ -2.0% -2.0% 29,000 ↓ -4.9% -4.9% 37,000 ↓ -3.9% -3.9% 24,000 ↓ -5.9% -5.9%
2015.03 2014/07/31 Q1予 299,000 → 0.0% 0.0% 30,500 → 0.0% 0.0% 38,500 → 0.0% 0.0% 25,500 → 0.0% 0.0%
2015.03 2014/05/12 当初予 299,000 - - - 30,500 - - - 38,500 - - - 25,500 - - -
2014.03 2014/05/12 実 295,957 - - - 41,683 - - - 51,244 - - - 32,692 - - -
シェア ツイート
ページトップへ戻る